Ian Clements, SVP Finance & Communications at Mirum Pharmaceuticals, Inc. (MIRM), bought 4,000 shares at $11.87 ($46K) on 2019-09-06, disclosed to the SEC on 2019-09-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.07 | 1,801 | $20K | 43.3% |
| 2 | $11.87 | 2,199 | $26K | 56.7% |
| Total | $11.51 avg | 4,000 | $46K | 100% |
| Filing → |
| MIRM | BUY | 2021-03-08 | $30K | — | Filing → |
| MIRM | BUY | 2020-12-28 | $46K | — | Filing → |